{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:59:18Z","timestamp":1779310758766,"version":"3.51.4"},"reference-count":51,"publisher":"Walter de Gruyter GmbH","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,12,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jbcpp-2017-0207_s_999_w2aab3b7b3b1b6b1aab1c17b1Aa\">\n                    <jats:title id=\"d512039e8405_w2aab3b7b3b1b6b1aab1c17b1aAa\">Background<\/jats:title>\n                    <jats:p>Testosterone, nandrolone, and stanozolol are among the highly consumed anabolic androgenic steroids (AASs). Although the desired effects of AAS are being achieved by the abusers, unfortunately, this leads to numerous physical and physiological side effects. The present study was designed to investigate and determine whether early pubertal exposure to AAS treatment had detrimental effects on blood testosterone and estradiol concentrations, mating behavior, and pregnancy outcome during the pubertal period in male rats.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2017-0207_s_998_w2aab3b7b3b1b6b1aab1c17b2Aa\">\n                    <jats:title id=\"d512039e8413_w2aab3b7b3b1b6b1aab1c17b2aAa\">Materials<\/jats:title>\n                    <jats:p>Early pubertal rats (PND41) were given two doses (2.5 mg\/kg and 5 mg\/kg) each of testosterone, nandrolone, and stanozolol subcutaneously for 6 weeks. Upon completion, three rats with the highest weight were chosen from each group for mating with the females, in a ratio of one male to two females for 10 days. After 10 days, all male rats were sacrificed to obtain the testes for weight recording, and blood samples were collected for testosterone and estradiol quantitation. Pregnant females were housed separately until birth, and the number of offsprings produced was counted.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2017-0207_s_997_w2aab3b7b3b1b6b1aab1c17b3Aa\">\n                    <jats:title id=\"d512039e8421_w2aab3b7b3b1b6b1aab1c17b3aAa\">Results<\/jats:title>\n                    <jats:p>The results clearly show a reduction in reproductive hormonal and behavioral parameters between testosterone and nandrolone, and testosterone and stanozolol. Stanozolol administration exhibited suppressing effects in all parameters including testicular weight deterioration, serum testosterone and estradiol reduction, low mating preferences, and declined pregnancy outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jbcpp-2017-0207_s_996_w2aab3b7b3b1b6b1aab1c17b4Aa\">\n                    <jats:title id=\"d512039e8429_w2aab3b7b3b1b6b1aab1c17b4aAa\">Conclusions<\/jats:title>\n                    <jats:p>AAS exposure during the onset of puberty results in reproductive detrimental effects, which are postulated to affect the pregnancy rate.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jbcpp-2017-0207","type":"journal-article","created":{"date-parts":[[2018,8,3]],"date-time":"2018-08-03T03:13:55Z","timestamp":1533266035000},"page":"29-36","source":"Crossref","is-referenced-by-count":1,"title":["Pubertal anabolic androgenic steroid exposure in male rats affects levels of gonadal steroids, mating frequency, and pregnancy outcome"],"prefix":"10.1515","volume":"30","author":[{"given":"Siti Syairah","family":"Mohd Mutalip","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Life Sciences, Faculty of Pharmacy , Universiti Teknologi MARA (UiTM) , Bandar Puncak Alam, Selangor , Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aishah Mohd","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Hospital Tuanku Ja\u2019afar , Kementerian Kesihatan Malaysia , Seremban, Negeri Sembilan , Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mashani","family":"Mohamad","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Life Sciences, Faculty of Pharmacy , Universiti Teknologi MARA (UiTM) , Bandar Puncak Alam, Selangor , Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasudevan","family":"Mani","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Toxicology , College of Pharmacy, Qassim University , Buraidah , Kingdom of Saudi Arabia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siti Nooraishah","family":"Hussin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Life Sciences, Faculty of Pharmacy , Universiti Teknologi MARA (UiTM) , Bandar Puncak Alam, Selangor , Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gurmeet Kaur","family":"Surindar Singh","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Life Sciences, Faculty of Pharmacy , Universiti Teknologi MARA (UiTM), Puncak Alam Campus , 42300 Bandar Puncak Alam, Selangor , Malaysia , Phone: +60332584751, Fax: +60332584602"},{"name":"Brain Degeneration and Therapeutics Group, Pharmaceutical and Life Sciences Community of Research , Universiti Teknologi MARA (UiTM) , Shah Alam, Selangor , Malaysia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,8,3]]},"reference":[{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_001_w2aab3b7b3b1b6b1ab1b7b1Aa","doi-asserted-by":"crossref","unstructured":"Fragkaki A, Angelis Y, Koupparis M, Tsantili-Kakoulidou A, Kokotos G, Georgakopoulos C. Structural characteristics of anabolic androgenic steroids contributing to binding to the androgen receptor and to their anabolic and androgenic activities: applied modifications in the steroidal structure. Steroids 2009;74:172\u201397.1902851210.1016\/j.steroids.2008.10.016","DOI":"10.1016\/j.steroids.2008.10.016"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_002_w2aab3b7b3b1b6b1ab1b7b2Aa","doi-asserted-by":"crossref","unstructured":"Kanayama G, Hudson JI, Pope HG. Long-term psychiatric and medical consequences of anabolic\u2013androgenic steroid abuse: a looming public health concern? Drug Alcohol Depend 2008;98:112.","DOI":"10.1016\/j.drugalcdep.2008.05.004"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_003_w2aab3b7b3b1b6b1ab1b7b3Aa","doi-asserted-by":"crossref","unstructured":"Handelsman DJ. Testosterone: use, misuse and abuse. Med J Aust 2006;185:436.17137434","DOI":"10.5694\/j.1326-5377.2006.tb00642.x"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_004_w2aab3b7b3b1b6b1ab1b7b4Aa","doi-asserted-by":"crossref","unstructured":"Mottram DR, George AJ. Anabolic steroids. Best Pract Res Clin Endocrinol Metab 2000;14:55\u201369.10.1053\/beem.2000.0053","DOI":"10.1053\/beem.2000.0053"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_005_w2aab3b7b3b1b6b1ab1b7b5Aa","doi-asserted-by":"crossref","unstructured":"Noorafshan A, Karbalay-Doust S, Ardekani FM. High doses of nandrolone decanoate reduce volume of testis and length of seminiferous tubules in rats. APMIS 2005;113:122\u20135.10.1111\/j.1600-0463.2005.apm1130205.x15723686","DOI":"10.1111\/j.1600-0463.2005.apm1130205.x"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_006_w2aab3b7b3b1b6b1ab1b7b6Aa","doi-asserted-by":"crossref","unstructured":"Salas-Ramirez KY, Montalto PR, Sisk CL. Anabolic androgenic steroids differentially affect social behaviors in adolescent and adult male Syrian hamsters. Horm Behav 2008;53:378\u201385.1820170410.1016\/j.yhbeh.2007.11.004","DOI":"10.1016\/j.yhbeh.2007.11.004"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_007_w2aab3b7b3b1b6b1ab1b7b7Aa","doi-asserted-by":"crossref","unstructured":"Wood RI. Reinforcing aspects of androgens. Physiol Behav 2004;83:279\u201389.10.1016\/j.physbeh.2004.08.01215488545","DOI":"10.1016\/S0031-9384(04)00350-6"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_008_w2aab3b7b3b1b6b1ab1b7b8Aa","doi-asserted-by":"crossref","unstructured":"Hickson RC, Ball KL, Falduto MT. Adverse effects of anabolic steroids. Med Toxicol Adverse Drug Exp 1989;4:254\u201371.10.1007\/BF032599122671596","DOI":"10.1007\/BF03259912"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_009_w2aab3b7b3b1b6b1ab1b7b9Aa","doi-asserted-by":"crossref","unstructured":"Kennedy M. Anabolic steroid abuse and toxicology. Intern Med J 1992;22:374\u201381.","DOI":"10.1111\/j.1445-5994.1992.tb02151.x"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_010_w2aab3b7b3b1b6b1ab1b7c10Aa","doi-asserted-by":"crossref","unstructured":"Maravelias C, Dona A, Stefanidou M, Spiliopoulou C. Adverse effects of anabolic steroids in athletes: a constant threat. Toxicol Lett 2005;158:167\u201375.1600516810.1016\/j.toxlet.2005.06.005","DOI":"10.1016\/j.toxlet.2005.06.005"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_011_w2aab3b7b3b1b6b1ab1b7c11Aa","doi-asserted-by":"crossref","unstructured":"Page ST, Herbst KL, Amory JK, Coviello AD, Anawalt BD, Matsumoto AM, et al. Testosterone administration suppresses adiponectin levels in men. J Androl 2005;26:85\u201392.15611571","DOI":"10.1002\/j.1939-4640.2005.tb02876.x"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_012_w2aab3b7b3b1b6b1ab1b7c12Aa","doi-asserted-by":"crossref","unstructured":"Durant RH, Rickert VI, Ashworth CS, Newman C, Slavens G. Use of multiple drugs among adolescents who use anabolic steroids. New Engld J Med 1993;328:922\u20136.10.1056\/NEJM199304013281304","DOI":"10.1056\/NEJM199304013281304"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_013_w2aab3b7b3b1b6b1ab1b7c13Aa","doi-asserted-by":"crossref","unstructured":"Kindlundh A, Isacson DG, Berglund L, Nyberg F. Factors associated with adolescent use of doping agents: anabolic-androgenic steroids. Addiction 1999;94:543\u201353.1060585010.1046\/j.1360-0443.1999.9445439.x","DOI":"10.1046\/j.1360-0443.1999.9445439.x"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_014_w2aab3b7b3b1b6b1ab1b7c14Aa","doi-asserted-by":"crossref","unstructured":"Kindlundh AM, Hagekull B, Isacson DG, Nyberg F. Adolescent use of anabolic \u2013 androgenic steroids and relations to self-reports of social, personality and health aspects. Eur J Public Health 2001;11:322\u20138.10.1093\/eurpub\/11.3.32211582614","DOI":"10.1093\/eurpub\/11.3.322"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_015_w2aab3b7b3b1b6b1ab1b7c15Aa","doi-asserted-by":"crossref","unstructured":"Lane JR, Connor JD. The influence of endogenous and exogenous sex hormones in adolescents with attention to oral contraceptives and anabolic steroids. J Adolesc Health 1994;15:6304.","DOI":"10.1016\/S1054-139X(94)90629-7"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_016_w2aab3b7b3b1b6b1ab1b7c16Aa","doi-asserted-by":"crossref","unstructured":"Bonetti A, Tirelli F, Catapano A, Dazzi D, Dei Cas A, Solito F, et al. Side effects of anabolic androgenic steroids abuse. Int J Sports Med 2008;29:679\u201387.10.1055\/s-2007-96580818004690","DOI":"10.1055\/s-2007-965808"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_017_w2aab3b7b3b1b6b1ab1b7c17Aa","unstructured":"Johnson LC, Fisher G, Silvester L, Hofheins CC. Anabolic steroid: effects on strength body weight oxygen uptake and spermatogenesis upon mature males. Med Sci Sports Spring 1972; 4:43\u20135."},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_018_w2aab3b7b3b1b6b1ab1b7c18Aa","doi-asserted-by":"crossref","unstructured":"Torres-Calleja J, De Celis R, Gonzalez-Unzaga M, Pedr\u00f3n-Nuevo N. Effect of androgenic anabolic steroids on semen parameters and hormone levels in bodybuilders. Fertil Steril 2000;74:1055\u20136.10.1016\/S0015-0282(00)01557-011056262","DOI":"10.1016\/S0015-0282(00)01557-0"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_019_w2aab3b7b3b1b6b1ab1b7c19Aa","doi-asserted-by":"crossref","unstructured":"Torres-Calleja J, Gonzalez-Unzaga M, DeCelis-Carrillo R, Calzada-Sanchez L, Pedron N. Effect of androgenic anabolic steroids on sperm quality and serum hormone levels in adult male bodybuilders. Life Sci 2001;68:1769\u201374.10.1016\/S0024-3205(01)00972-911270623","DOI":"10.1016\/S0024-3205(01)00972-9"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_020_w2aab3b7b3b1b6b1ab1b7c20Aa","doi-asserted-by":"crossref","unstructured":"Evans NA. Current concepts in anabolic-androgenic steroids. Am J Sports Med 2004;32:534\u201342.10.1177\/036354650326220214977687","DOI":"10.1177\/0363546503262202"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_021_w2aab3b7b3b1b6b1ab1b7c21Aa","doi-asserted-by":"crossref","unstructured":"Hartgens F, Kuipers H. Effects of androgenic-anabolic steroids in athletes. Sports Med 2004;34:513\u201354.10.2165\/00007256-200434080-0000315248788","DOI":"10.2165\/00007256-200434080-00003"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_022_w2aab3b7b3b1b6b1ab1b7c22Aa","doi-asserted-by":"crossref","unstructured":"Dickerman RD, McConathy WJ, Zachariah NY. Testosterone, sex hormone-binding globulin, lipoproteins, and vascular disease risk. J Cardiovasc Risk 1997;4:363\u20136.9865668","DOI":"10.1097\/00043798-199710000-00008"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_023_w2aab3b7b3b1b6b1ab1b7c23Aa","doi-asserted-by":"crossref","unstructured":"Lenders J, Demacker P, Vos J, Jansen P, Hoitsma A, Van\u2019t Laar A, et al. Deleterious effects of anabolic steroids on serum lipoproteins, blood pressure, and liver function in amateur body builders. Int J Sports Med 1988;9:19\u201323.336651410.1055\/s-2007-1024972","DOI":"10.1055\/s-2007-1024972"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_024_w2aab3b7b3b1b6b1ab1b7c24Aa","doi-asserted-by":"crossref","unstructured":"Neto OB, da Mota GR, De Sordi CC, Resende EA, Resende LA, da Silva MA, et al. Long-term anabolic steroids in male bodybuilders induce cardiovascular structural and autonomic abnormalities. Clin Auton Res 2018;28:231\u201344.2901901810.1007\/s10286-017-0470-2","DOI":"10.1007\/s10286-017-0470-2"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_025_w2aab3b7b3b1b6b1ab1b7c25Aa","unstructured":"Burnett KF, Kleiman ME. Psychological characteristics of adolescent steroid users. Adolescence 1994;29:81.8036984"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_026_w2aab3b7b3b1b6b1ab1b7c26Aa","doi-asserted-by":"crossref","unstructured":"DuRant RH, Escobedo LG, Heath GW. Anabolic-steroid use, strength training, and multiple drug use among adolescents in the United States. Pediatrics 1995;96:23\u20138.7596717","DOI":"10.1542\/peds.96.1.23"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_027_w2aab3b7b3b1b6b1ab1b7c27Aa","doi-asserted-by":"crossref","unstructured":"Johnson MD. Anabolic steroid use in adolescent athletes. Pediatr Clin North Am 1990;37:1111\u201323.10.1016\/S0031-3955(16)36977-22216557","DOI":"10.1016\/S0031-3955(16)36977-2"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_028_w2aab3b7b3b1b6b1ab1b7c28Aa","doi-asserted-by":"crossref","unstructured":"Tanner SM, Miller DW, Alongi C. Anabolic steroid use by adolescents: prevalence, motives, and knowledge of risks. Clin J Sports Med 1995;5:108\u201315.10.1097\/00042752-199504000-00007","DOI":"10.1097\/00042752-199504000-00007"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_029_w2aab3b7b3b1b6b1ab1b7c29Aa","unstructured":"Mutalip SS, Singh GK, Shah AM, Mohamad M, Mani V, Hussin SN. Histological changes in testes of rats treated with testosterone, nandrolone, and stanozolol. Iran J Reprod Med 2013;11:653.24639803"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_030_w2aab3b7b3b1b6b1ab1b7c30Aa","doi-asserted-by":"crossref","unstructured":"Bahrke MS, Yesalis CE, Wright JE. Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. Sports Med 1990;10:303\u201337.10.2165\/00007256-199010050-000032263798","DOI":"10.2165\/00007256-199010050-00003"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_031_w2aab3b7b3b1b6b1ab1b7c31Aa","doi-asserted-by":"crossref","unstructured":"Bueno A, Carvalho FB, Gutierres JM, Lhamas C, Andrade CM. A comparative study of the effect of the dose and exposure duration of anabolic androgenic steroids on behavior, cholinergic regulation, and oxidative stress in rats. PLoS One 2017;12:e0177623.10.1371\/journal.pone.017762328594925","DOI":"10.1371\/journal.pone.0177623"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_032_w2aab3b7b3b1b6b1ab1b7c32Aa","doi-asserted-by":"crossref","unstructured":"Bueno A, Carvalho FB, Gutierres JM, Lhamas CL, Brusco I, Oliveira SM, et al. Impacts of dose and time of boldenone and stanazolol exposure in inflammatory markers, oxidative and nitrosative stress and histopathological changes in the rat testes. Theriogenology 2017;90:101\u20138.2816695410.1016\/j.theriogenology.2016.11.024","DOI":"10.1016\/j.theriogenology.2016.11.024"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_033_w2aab3b7b3b1b6b1ab1b7c33Aa","unstructured":"Hijazi MM, Azmi MA, Hussain A, Naqvi S, Perveen R, Hijazi S. Androgenic anabolic steroidal-based effects on the morphology of testicular structures of albino rats. Pakistan J Zool 2012;44:1529\u201337."},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_034_w2aab3b7b3b1b6b1ab1b7c34Aa","doi-asserted-by":"crossref","unstructured":"Mulcahey MK, Schiller JR, Hulstyn MJ. Anabolic steroid use in adolescents: identification of those at risk and strategies for prevention. Phys Sportsmed 2010;38:105\u201313.2095970310.3810\/psm.2010.10.1815","DOI":"10.3810\/psm.2010.10.1815"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_035_w2aab3b7b3b1b6b1ab1b7c35Aa","doi-asserted-by":"crossref","unstructured":"Denham BE. Determinants of anabolic-androgenic steroid risk perceptions in youth populations: a multivariate analysis. J Health Soc Behav 2009;50:277\u201392.10.1177\/00221465090500030319711806","DOI":"10.1177\/002214650905000303"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_036_w2aab3b7b3b1b6b1ab1b7c36Aa","doi-asserted-by":"crossref","unstructured":"Saartok T, Dahlberg E, Gustafsson J-A. Relative binding affinity of anabolic-androgenic steroids: comparison of the binding to the androgen receptors in skeletal muscle and in prostate, as well as to sex hormone-binding globulin. Endocrinology 1984;114:2100\u20136.10.1210\/endo-114-6-21006539197","DOI":"10.1210\/endo-114-6-2100"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_037_w2aab3b7b3b1b6b1ab1b7c37Aa","doi-asserted-by":"crossref","unstructured":"Ojasoo T, Delettre J, Mornon J, Turpin-VanDycke C, Raynaud J. Towards the mapping of the progesterone and androgen receptors. J Steroid Biochem 1987;27:255\u201369.10.1016\/0022-4731(87)90317-73695484","DOI":"10.1016\/0022-4731(87)90317-7"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_038_w2aab3b7b3b1b6b1ab1b7c38Aa","doi-asserted-by":"crossref","unstructured":"Yoshiji S, Yamamoto T, Okada H. Aromatization of androstenedione and 19-nortestosterone in human placenta, liver and adipose tissues. Nihon Naibunpi Gakkai Zasshi 1986;62:18\u201325.3699194","DOI":"10.1507\/endocrine1927.62.1_18"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_039_w2aab3b7b3b1b6b1ab1b7c39Aa","doi-asserted-by":"crossref","unstructured":"McGinnis MY, Lumia AR, Possidente BP. Effects of withdrawal from anabolic androgenic steroids on aggression in adult male rats. Physiol Behav 2002;75:541\u20139.10.1016\/S0031-9384(02)00657-112062318","DOI":"10.1016\/S0031-9384(02)00657-1"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_040_w2aab3b7b3b1b6b1ab1b7c40Aa","doi-asserted-by":"crossref","unstructured":"Clark AS, Barber DM. Anabolic-androgenic steroids and aggression in castrated male rats. Physiol Behav 1994;56:1107\u201313.782457910.1016\/0031-9384(94)90351-4","DOI":"10.1016\/0031-9384(94)90351-4"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_041_w2aab3b7b3b1b6b1ab1b7c41Aa","doi-asserted-by":"crossref","unstructured":"Long SF, Wilson MC, Sufka KJ, Davis WM. The effects of cocaine and nandrolone co-administration on aggression in male rats. Prog Neuropsychopharmacol Biol Psychiatry 1996;20:839\u201356.887006810.1016\/0278-5846(96)00063-2","DOI":"10.1016\/0278-5846(96)00063-2"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_042_w2aab3b7b3b1b6b1ab1b7c42Aa","doi-asserted-by":"crossref","unstructured":"McGinnis MY. Anabolic androgenic steroids and aggression: studies using animal models. Ann N Y Acad Sci 2004;1036:399\u2013415.15817752","DOI":"10.1196\/annals.1330.024"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_043_w2aab3b7b3b1b6b1ab1b7c43Aa","doi-asserted-by":"crossref","unstructured":"McGinnis MY, Lumia AR, Breuer ME, Possidente B. Physical provocation potentiates aggression in male rats receiving anabolic androgenic steroids. Horm Behav 2002;41:101\u201310.10.1006\/hbeh.2001.174211863388","DOI":"10.1006\/hbeh.2001.1742"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_044_w2aab3b7b3b1b6b1ab1b7c44Aa","doi-asserted-by":"crossref","unstructured":"Roselli CE. The effect of anabolic\u2013androgenic steroids on aromatase activity and androgen receptor binding in the rat preoptic area. Brain Res 1998;792:271\u20136.10.1016\/S0006-8993(98)00148-69593936","DOI":"10.1016\/S0006-8993(98)00148-6"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_045_w2aab3b7b3b1b6b1ab1b7c45Aa","doi-asserted-by":"crossref","unstructured":"Wesson DW, McGinnis MY. Stacking anabolic androgenic steroids (AAS) during puberty in rats: a neuroendocrine and behavioral assessment. Pharmacol Biochem Behav 2006;83:410\u20139.10.1016\/j.pbb.2006.03.00116603236","DOI":"10.1016\/j.pbb.2006.03.001"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_046_w2aab3b7b3b1b6b1ab1b7c46Aa","doi-asserted-by":"crossref","unstructured":"Winters SJ. Androgens: endocrine physiology and pharmacology. NIDA Res Monogr 1990;102:113\u201330.2079969","DOI":"10.1037\/e496332006-007"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_047_w2aab3b7b3b1b6b1ab1b7c47Aa","doi-asserted-by":"crossref","unstructured":"Martinez-Sanchis S, Brain P, Salvador A, Simon V. Long- term chronic treatment with stanozolol lacks significant effects on aggression and activity in young and adult male laboratory mice. Gen Pharmacol Vascul Syst 1996;27: 293\u20138.10.1016\/0306-3623(95)02019-5","DOI":"10.1016\/0306-3623(95)02019-5"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_048_w2aab3b7b3b1b6b1ab1b7c48Aa","doi-asserted-by":"crossref","unstructured":"Farrell SF, McGinnis MY. Long-term effects of pubertal anabolic\u2013androgenic steroid exposure on reproductive and aggressive behaviors in male rats. Horm Behav 2004;46:193\u2013203.10.1016\/j.yhbeh.2004.03.01215256309","DOI":"10.1016\/j.yhbeh.2004.03.012"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_049_w2aab3b7b3b1b6b1ab1b7c49Aa","doi-asserted-by":"crossref","unstructured":"Breuer ME, McGinnis MY, Lumia AR, Possidente BP. Aggression in male rats receiving anabolic androgenic steroids: effects of social and environmental provocation. Horm Behav 2001;40:409\u201318.10.1006\/hbeh.2001.170611673914","DOI":"10.1006\/hbeh.2001.1706"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_050_w2aab3b7b3b1b6b1ab1b7c50Aa","doi-asserted-by":"crossref","unstructured":"Keleta YB, Lumia AR, Anderson GM, McGinnis MY. Behavioral effects of pubertal anabolic androgenic steroid exposure in male rats with low serotonin. Brain Res 2007;1132:129\u201338.10.1016\/j.brainres.2006.10.09717194457","DOI":"10.1016\/j.brainres.2006.10.097"},{"key":"2025121209214162322_j_jbcpp-2017-0207_ref_051_w2aab3b7b3b1b6b1ab1b7c51Aa","doi-asserted-by":"crossref","unstructured":"Cunningham RL, Claiborne BJ, McGinnis MY. Pubertal exposure to anabolic androgenic steroids increases spine densities on neurons in the limbic system of male rats. Neuroscience 2007;150:60915.","DOI":"10.1016\/j.neuroscience.2007.09.038"}],"container-title":["Journal of Basic and Clinical Physiology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/jbcpp.2019.30.issue-1\/jbcpp-2017-0207\/jbcpp-2017-0207.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2017-0207\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2017-0207\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:18:23Z","timestamp":1765541903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jbcpp-2017-0207\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,3]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,9,6]]},"published-print":{"date-parts":[[2018,12,19]]}},"alternative-id":["10.1515\/jbcpp-2017-0207"],"URL":"https:\/\/doi.org\/10.1515\/jbcpp-2017-0207","relation":{},"ISSN":["2191-0286","0792-6855"],"issn-type":[{"value":"2191-0286","type":"electronic"},{"value":"0792-6855","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8,3]]}}}